The Adverse Outcome Pathway approach in nanotoxicology
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
An Adverse Outcome Pathway (AOP) is a conceptual construct that describes existing knowledge on the link between a molecular initiating event and an adverse outcome. A sequential chain of causally related events is portrayed at different levels of biological organisation. AOPs are considered to be useful mechanistic blueprints for the development of novel tools for human and environmental risk assessment. Following OECD guidance, an increasing number of AOPs for chemically-induced adverse effects in humans and environmental species are being proposed. Due to their unique properties, the toxicity of nanomaterials (NMs) and chemicals is often difficult to directly compare since their mechanisms usually differ. While there are still many knowledge gaps in our understanding of NM toxicity, an ever increasing number of mechanistic studies are shedding light on their toxicokinetic and toxicodynamic properties. In this paper, we introduce the concept of AOPs and analyse its possible implementation for nanotoxicology. We illustrate how the AOP framework can be used to rationally combine mechanistic knowledge relating to both NM- and chemically-induced liver toxicity to fill information gaps and guide the development of toxicity testing strategies. The differences between NM and chemically-induced adversity are proposed to be primarily related to differences in toxicokinetics and the nature of the initial Key Events in the AOP. Consequently, much of the mechanistic knowledge captured by AOPs that have been developed from consideration of chemically-induced toxicity is also relevant to describe AOPs applicable to NMs, at least in qualitative terms, and thus can be used to inform predictive modelling and risk assessment of NM toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Ankley, G. T., Bennett, R. S., Erickson, R. J., Hoff, D. J., Hornung, M. W., Johnson, R. D., Mount, D. R., Nichols, J. W., Russom, C. L., Schmieder, P. K., et al. (2009) · Environmental Toxicology and Chemistry · doi:10.1002/etc.34 · Cited by 2,734
Longmire, M., Choyke, P. L., & Kobayashi, H. (2008) · Nanomedicine · doi:10.2217/17435889.3.5.703 · Cited by 2,149
Drug-induced oxidative stress and toxicity
Deavall, D. G., Martin, E. A., Horner, J. M., & Roberts, R. (2012) · Journal of Toxicology · doi:10.1155/2012/645460 · Cited by 689
Geraets, L., Oomen, A. G., Schroeter, J. D., Coleman, V. A., & Cassee, F. R. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs113 · Cited by 176
Cited by
The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors
Izci, M., Maksoudian, C., Manshian, B. B., & Soenen, S. J. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00779 · Cited by 506
Nanotechnology and artificial intelligence to enable sustainable and precision agriculture
Zhang, P., Guo, Z., Ullah, S., Melagraki, G., Afantitis, A., & Lynch, I. (2021) · Nature Plants · doi:10.1038/s41477-021-00946-6 · Cited by 478
EFSA Scientific Committee, Hardy, A., Benford, D., Halldorsson, T., Jeger, M. J., Knutsen, H. K., More, S., Naegeli, H., Noteborn, H., Ockleford, C., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5327 · Cited by 416
EFSA Scientific Committee, More, S., Bampidis, V., Benford, D., Bragard, C., Halldorsson, T., Hernández‐Jerez, A., Hougaard Bennekou, S., Koutsoumanis, K., Lambré, C., et al. (2021) · EFSA Journal · doi:10.2903/j.efsa.2021.6768 · Cited by 395
Halappanavar, S., van den Brule, S., Nymark, P., Gaté, L., Seidel, C., Valentino, S., Zhernovkov, V., Høgh Danielsen, P., De Vizcaya, A., Wolff, H., et al. (2020) · Particle and Fibre Toxicology · doi:10.1186/s12989-020-00344-4 · Cited by 246
Metadata
- Authors
- Gerloff, K., Landesmann, B., Worth, A., Munn, S., Palosaari, T., & Whelan, M.
- Venue
- Computational Toxicology
- Publisher
- Elsevier BV
- Published
- 2017-02
- Volume
- 1
- Pages
- 3-11
- ISSN
- 2468-1113 (ISSN-L)
- OpenAlex
- W2512797033
- Cited by
- 104
- References
- 5
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Adverse Outcome Pathway approach in nanotoxicology. https://app.cochat.ai/papers/10.1016/j.comtox.2016.07.001
- The paper
- Gerloff, K., Landesmann, B., Worth, A., Munn, S., Palosaari, T., & Whelan, M. (2017). The Adverse Outcome Pathway approach in nanotoxicology. Computational Toxicology. https://doi.org/10.1016/j.comtox.2016.07.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.